| 000 | 01600 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517231104.0 | ||
| 264 | 0 | _c20190325 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1873-5835 | ||
| 024 | 7 |
_a10.1016/j.leukres.2018.07.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Seok-Hyun | |
| 245 | 0 | 0 |
_aPrognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP. _h[electronic resource] |
| 260 |
_bLeukemia research _c08 2018 |
||
| 300 |
_a100-105 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aCyclophosphamide |
| 650 | 0 | 4 | _aDoxorubicin |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlobins _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrednisone |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSerum Albumin _xanalysis |
| 650 | 0 | 4 | _aVincristine |
| 700 | 1 | _aGo, Se-Il | |
| 700 | 1 | _aSeo, Jangho | |
| 700 | 1 | _aKang, Myoung Hee | |
| 700 | 1 | _aPark, Sung Woo | |
| 700 | 1 | _aKim, Hoon-Gu | |
| 700 | 1 | _aLee, Gyeong-Won | |
| 773 | 0 |
_tLeukemia research _gvol. 71 _gp. 100-105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2018.07.014 _zAvailable from publisher's website |
| 999 |
_c28672252 _d28672252 |
||